In yet another analysis, the main findings of 19 case-control studies, including 2,240 cases and 5,246 controls, were similar to those of the present study, though the subgroup analysis indicated a marginal association between the TP53 Arg72Pro polymorphism and ovarian cancer risk in the heterozygote model in Caucasians [43]. The gene discussed is TP53; the disease is ovarian cancer.